From: RPL35A is a key promotor involved in the development and progression of gastric cancer
Features | No. of patients | RPL35A expression | P value | |
---|---|---|---|---|
Low | High | |||
All patients | 110 | 65 | 45 | Â |
Age (years) | Â | Â | Â | 0.070 |
 < 64 | 53 | 36 | 17 |  |
 ≥ 64 | 57 | 29 | 28 |  |
Gender | Â | Â | Â | 0.869 |
 Male | 84 | 50 | 34 |  |
 Female | 26 | 15 | 11 |  |
T Infiltrate | Â | Â | Â | 0.042 |
 T1 | 5 | 4 | 1 |  |
 T2 | 17 | 11 | 6 |  |
 T3 | 65 | 41 | 24 |  |
 T4 | 23 | 9 | 14 |  |
Lymphatic metastasis (N) | Â | Â | Â | 0.754 |
 N0 | 20 | 13 | 7 |  |
 N1 | 18 | 12 | 6 |  |
 N2 | 26 | 12 | 14 |  |
 N3 | 46 | 28 | 18 |  |
Stage | Â | Â | Â | 0.631 |
 I | 9 | 5 | 4 |  |
 II | 32 | 21 | 11 |  |
 III | 68 | 38 | 30 |  |
 IV | 1 | 1 | 0 |  |
Tumor size | Â | Â | Â | 0.591 |
 < 5 cm | 46 | 26 | 20 |  |
 ≥ 5 cm | 55 | 34 | 21 |  |
Vessel carcinoma embolus | Â | Â | Â | 0.539 |
 0 | 26 | 14 | 12 |  |
 1 | 54 | 33 | 21 |  |
Nerve tumor infiltrates | Â | Â | Â | 0.425 |
 0 | 36 | 22 | 14 |  |
 1 | 20 | 10 | 10 |  |
Expession of Ki67 | Â | Â | Â | 0.404 |
 < 60% | 47 | 25 | 22 |  |
 ≥ 60% | 52 | 32 | 20 |  |
Expession of CD34 | Â | Â | Â | 0.346 |
 No | 15 | 6 | 9 |  |
 Yes | 29 | 16 | 13 |  |
Expession of EGFR | Â | Â | Â | 0.531 |
 No | 85 | 47 | 38 |  |
 Yes | 14 | 9 | 5 |  |
Expession of VEGF | Â | Â | Â | 0.343 |
 No | 34 | 17 | 17 |  |
 Yes | 65 | 39 | 26 |  |
Expession of CDX2 | Â | Â | Â | 0.892 |
 No | 18 | 10 | 8 |  |
 Yes | 82 | 47 | 35 |  |
Expession of Her2 | Â | Â | Â | 0.948 |
 No | 72 | 41 | 31 |  |
 Yes | 26 | 15 | 11 |  |